Participated · Equity · Dec 2022

MediNav provides an AI digital assistant that listens to doctors' dictated exam results, extracts relevant data, and inserts it into structured reports across multiple fields which the clinician then verifies and saves. The assistant handles complex exams (e.g., ultrasounds or multi-field consultations) by separating and placing information in the proper report locations and learns from corrections. The product runs on laptops, tablets or smartphones without a dedicated microphone. Radiologists using MediNav save at least 40% of the time needed to write results, and in emergencies the tool reduces ambulance-form completion time by threefold. The company plans in 2023 to add at least one more language, expand commercially to Germany and/or Latin America, and develop into more complex specialties such as cardiology and emergencies. To date MediNav has used its funding to advance product development and sales and marketing.

Participated · Seed · Nov 2022

Licenseware develops a platform aimed at giving organizations visibility and governance over software assets and IT licensing costs. The company has been validated by enterprise customers and is described by its investor as mature and competitive in global markets. Licenseware's platform targets software asset management, an area where large organizations can incur unnoticed losses. The company is based in Romania. Public reporting on its financials, user metrics, or prior funding was not provided in the articles.

Led · Seed · Aug 2022

OctaiPipe is a UK-based artificial intelligence company focused on reducing the energy footprint of data centers by continuously optimizing their cooling infrastructure. Its platform combines federated learning, multi-agent reinforcement learning, and digital-twin modeling to adjust cooling operations on site, preserving data control while meeting safety and regulatory requirements. By acting like an “orchestra conductor,” the software fine-tunes chillers, fans, and pumps to match actual cooling demand, delivering immediate efficiency gains and lower carbon emissions. The system is deployed locally rather than in the cloud, appealing to operators that prioritize security and scalability. A defined product roadmap, developed in partnership with ABB, targets further enhancements in reliability and performance across broader data-center operations. Financial details on OctaiPipe’s current revenues, customer base, or prior funding have not been disclosed. The recent strategic investment from ABB provides fresh capital and a powerful go-to-market channel to accelerate adoption.

Participated · Seed · Jul 2022

Milluu provides a mobile app and Milluu Bot that lets business users present apartments, schedule visits, sign contracts, secure goods, and pay utility bills while tenants search and receive personalized offers. The company charges owners a 20% setup fee and then a 10% monthly subscription, and charges tenants a 6% monthly fee. Milluu currently manages over 200 apartments and reports roughly €13K in monthly recurring revenue. The team is developing AI and ML features to improve matchmaking and automation. Milluu plans to scale to additional Romanian cities like Cluj and Iasi and expand across Poland, with a longer-term goal of a Series A in 2023 and targets of 20K managed units and nearly €20M in annual revenue.

Participated · Seed · Feb 2022

Rayscape develops a complex AI-powered digital assistant that aids radiologists in analyzing medical images such as chest X-rays and lung CT scans. Its tools include automatic detection and tracking of lung nodules to improve diagnostic speed and accuracy. The company was co-founded in 2018 by Andrei Tenescu, Bogdan Bercean, Cristian Avramescu, and Stefan Iarca and is based in Timisoara, Romania. In March 2024 Rayscape raised $500K in external funding. The company plans to use the funds to fuel expansion into the USA. No revenue or user metrics are reported in the articles. XVision develops AI-powered medical imaging software focused on chest X-rays and lung CT scans to speed up and improve radiologists' analyses. The company offers two products: one for chest CT analysis and another for chest X-rays, and has proven use cases via pilot projects and accelerator support. XVision reports processing over 26,000 chest X-rays and 10,000 lung CTs per month across more than 60 clinics and hospitals, including the Regina Maria private clinic chain. The founding team of four colleagues from Timişoara Technical University combines technical and business roles and gained early traction through pilots and Techcelerator. With the new financing, XVision plans to expand into Western Europe and North America and has started assembling a sales and business development team in Germany. The company also plans to extend its product catalog beyond lungs, exploring other body parts and potential oncology use cases.